glp 1 decrease inflammation The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists Antiinflammatory actions of glucagon-like peptide-1–based

one dose of 5 grams

[DOI] [PubMed] [Google Scholar] Cedergreen N, Ritz C, Streibig JC

Adverse side effects from GLP-1 receptor agonists are mostly gastrointestinal but may also include loss of muscle and bone mass

Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle

Blood 113, 39903998

During sample collection an assessment as to whether an individual was affected with konzo was conducted following the WHOs 3 main criteria for diagnosis including evidence of (1) a visible symmetric spastic abnormality of gait while walking or running, (2) a history of onset of less than 1 week followed by a nonprogressive course in a formerly healthy person, and (3) bilaterally exaggerated knee or ankle jerks without signs of disease of the spine